The study, the first of its kind to use the satellite-based global positioning system to provide the animals' locations, involved tagging 14 African elephants with sophisticated radio collars and monitoring their movements for several months.
Pfizer and Bristol were already positioning Eliquis as being the option for patients who refuse to take warfarin, having run a clever study that compared the drug to aspirin.